Drug Resistance and Transmission among Human Immunodeficiency Virus-Infected Patients in Ho Chi Minh City, Vietnam.

Trinh Quynh Mai, Elena Martinez, Ranjeeta Menon, Nguyen Thi Van Anh, Nguyen Tran Hien, Ben J Marais, Vitali Sintchenko
Author Information
  1. Trinh Quynh Mai: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  2. Elena Martinez: Centre for Infectious Disease and Microbiology-Public Health, ICPMR, Westmead Hospital, Sydney, Australia.
  3. Ranjeeta Menon: Centre for Infectious Disease and Microbiology-Public Health, ICPMR, Westmead Hospital, Sydney, Australia.
  4. Nguyen Thi Van Anh: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  5. Nguyen Tran Hien: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  6. Ben J Marais: Sydney Medical School and Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, Australia.
  7. Vitali Sintchenko: Centre for Infectious Disease and Microbiology-Public Health, ICPMR, Westmead Hospital, Sydney, Australia.

Abstract

Vietnam has a high burden of tuberculosis (TB) and multidrug-resistant (MDR) TB, but drug resistance patterns and TB transmission dynamics among TB/human immunodeficiency virus (HIV) coinfected patients are not well described. We characterized 200 isolates from TB/HIV coinfected patients diagnosed at the main TB referral hospital in Ho Chi Minh City, Vietnam. Phenotypic drug susceptibility testing (DST) for first-line drugs, spoligotyping, and 24-locus mycobacterial interspersed repetitive unit (MIRU-24) analysis was performed on all isolates. The 24-locus mycobacterial interspersed repetitive unit clusters and MDR isolates were subjected to whole genome sequencing (WGS). Most of the TB/HIV coinfected patients were young (162/174; 93.1% aged < 45 years) males (173; 86.5% male). Beijing (98; 49.0%) and Indo-Oceanic (70; 35.0%) lineage strains were most common. Phenotypic drug resistance was detected in 84 (42.0%) isolates, of which 17 (8.5%) were MDR; three additional MDR strains were identified on WGS. Strain clustering was reduced from 84.0% with spoligotyping to 20.0% with MIRU-24 typing and to 13.5% with WGS. Whole genome sequencing identified five additional clusters, or members of clusters, not recognized by MIRU-24. In total, 13 small (two to three member) WGS clusters were identified, with less clustering among drug susceptible (2/27; 7.4%) than among drug-resistant strains (25/27; 92.6%). On phylogenetic analysis, strains from TB/HIV coinfected patients were interspersed among strains from the general community; no major clusters indicating transmission among people living with HIV were detected. Tuberculosis/HIV coinfection in Vietnam was associated with high rates of drug resistance and limited genomic evidence of ongoing transmission among HIV-infected patients.

References

  1. Int J Tuberc Lung Dis. 2009 Sep;13(9):1142-7 [PMID: 19723405]
  2. N Engl J Med. 2012 Jun 7;366(23):2161-70 [PMID: 22670902]
  3. Lancet Infect Dis. 2007 May;7(5):328-37 [PMID: 17448936]
  4. J Clin Microbiol. 2013 Aug;51(8):2633-40 [PMID: 23761144]
  5. Int J Tuberc Lung Dis. 2006 Feb;10(2):160-6 [PMID: 16499254]
  6. Nat Genet. 2018 Feb;50(2):307-316 [PMID: 29358649]
  7. PLoS One. 2010 Mar 10;5(3):e9490 [PMID: 20224823]
  8. J Clin Microbiol. 2006 Jul;44(7):2333-7 [PMID: 16825345]
  9. J Clin Microbiol. 2006 Jan;44(1):20-8 [PMID: 16390942]
  10. Lancet. 2006 Nov 4;368(9547):1575-80 [PMID: 17084757]
  11. Antimicrob Agents Chemother. 2009 Oct;53(10):4498-500 [PMID: 19687244]
  12. Int J Tuberc Lung Dis. 2011 Jan;15(1):77-83 [PMID: 21276301]
  13. Int J Tuberc Lung Dis. 2017 Mar 1;21(3):297-302 [PMID: 28225339]
  14. PLoS One. 2016 Mar 22;11(3):e0149806 [PMID: 27003160]
  15. N Engl J Med. 2015 Mar 19;372(12):1181-2 [PMID: 25785984]
  16. Sci Rep. 2017 Apr 20;7:46327 [PMID: 28425484]
  17. PLoS One. 2016 Oct 13;11(10):e0163612 [PMID: 27737005]
  18. Int J Tuberc Lung Dis. 2011 Jan;15(1):116-24 [PMID: 21276307]
  19. J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19408 [PMID: 25724504]
  20. J Glob Antimicrob Resist. 2016 Mar;4:5-10 [PMID: 27436385]
  21. Mol Biol Evol. 2014 Sep;31(9):2472-82 [PMID: 24874208]
  22. Int J Tuberc Lung Dis. 2015 Nov;19(11):1276-89 [PMID: 26467578]
  23. Int J Infect Dis. 2014 Jan;18:14-21 [PMID: 24211230]
  24. Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30 [PMID: 19861002]
  25. Emerg Microbes Infect. 2014 Mar;3(3):e19 [PMID: 26038513]
  26. PLoS One. 2016 Apr 20;11(4):e0153563 [PMID: 27096759]
  27. BMC Infect Dis. 2014 Aug 23;14:455 [PMID: 25149181]
  28. J Clin Microbiol. 1997 Apr;35(4):907-14 [PMID: 9157152]
  29. Western Pac Surveill Response J. 2015 Feb 09;6(1):7-14 [PMID: 25960918]
  30. Lancet Respir Med. 2016 Jan;4(1):49-58 [PMID: 26669893]
  31. J Antimicrob Chemother. 2010 Nov;65(11):2341-6 [PMID: 20802233]
  32. J Glob Antimicrob Resist. 2017 Sep;10:154-160 [PMID: 28743648]
  33. Lancet Infect Dis. 2015 Oct;15(10):1193-1202 [PMID: 26116186]
  34. J Clin Microbiol. 2006 Dec;44(12):4498-510 [PMID: 17005759]
  35. J Clin Microbiol. 2013 Jun;51(6):1818-25 [PMID: 23554196]
  36. mBio. 2017 Aug 29;8(4): [PMID: 28851844]
  37. Int J Infect Dis. 2016 May;46:56-60 [PMID: 27044521]
  38. Lancet Infect Dis. 2013 Jun;13(6):529-39 [PMID: 23531391]
  39. Nat Genet. 2018 Jun;50(6):849-856 [PMID: 29785015]
  40. J Clin Microbiol. 2017 Jun;55(6):1871-1882 [PMID: 28381603]
  41. BMC Infect Dis. 2017 Jan 6;17(1):36 [PMID: 28061832]
  42. Lancet. 2012 May 19;379(9829):1902-13 [PMID: 22608339]
  43. PLoS One. 2013 Aug 13;8(8):e71867 [PMID: 23967255]
  44. Int J Tuberc Lung Dis. 2012 Apr;16(4):527-31 [PMID: 22640514]
  45. Eur Respir J. 2005 Mar;25(3):564-9 [PMID: 15738303]
  46. Lancet. 2007 Oct 27;370(9597):1500-7 [PMID: 17964351]
  47. J Clin Microbiol. 2014 Oct;52(10):3795-8 [PMID: 25078914]
  48. Tuberculosis (Edinb). 2016 Dec;101:49-53 [PMID: 27865397]
  49. PLoS One. 2014 Mar 13;9(3):e90868 [PMID: 24625669]
  50. Int J Infect Dis. 2017 Mar;56:14-20 [PMID: 28163165]
  51. Int J Tuberc Lung Dis. 2015 Aug;19(8):969-78 [PMID: 26162364]
  52. Antimicrob Agents Chemother. 2007 Dec;51(12):4515-7 [PMID: 17846128]

MeSH Term

Adolescent
Adult
Antitubercular Agents
Coinfection
Drug Resistance, Multiple, Bacterial
Female
Genome, Bacterial
Genotype
HIV
HIV Infections
Humans
Male
Middle Aged
Minisatellite Repeats
Multigene Family
Mycobacterium tuberculosis
Phylogeny
Retrospective Studies
Tuberculosis, Multidrug-Resistant
Vietnam
Whole Genome Sequencing

Chemicals

Antitubercular Agents

Word Cloud

Created with Highcharts 10.0.0amongdrugpatientsclusters0%strainsVietnamTBMDRcoinfectedisolatesWGSresistancetransmissionTB/HIVinterspersedMIRU-245%identifiedhighHIVHoChiMinhCityPhenotypicspoligotyping24-locusmycobacterialrepetitiveunitanalysisgenomesequencingdetected84threeadditionalclustering13burdentuberculosismultidrug-resistantpatternsdynamicsTB/humanimmunodeficiencyviruswelldescribedcharacterized200diagnosedmainreferralhospitalsusceptibilitytestingDSTfirst-linedrugsperformedsubjectedwholeyoung162/174931%aged<45yearsmales17386maleBeijing9849Indo-Oceanic7035lineagecommon42178Strainreduced20typingWholefivemembersrecognizedtotalsmalltwomemberlesssusceptible2/2774%drug-resistant25/27926%phylogeneticgeneralcommunitymajorindicatingpeoplelivingTuberculosis/HIVcoinfectionassociatedrateslimitedgenomicevidenceongoingHIV-infectedDrugResistanceTransmissionHumanImmunodeficiencyVirus-InfectedPatients

Similar Articles

Cited By